Atlas Trials

An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer

Clinical trial NCT03077698 · TERMINATED

Trial details

NCT number
NCT03077698
Sponsor
Xenetic Biosciences, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Endometrial Cancer
Start date
2017-06-14
Primary completion
2020-07-17
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.